These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33338704)

  • 1. Insulin Resistance is Significantly Related with Worse Clinical Outcomes in Non-Diabetic Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Yang X; Li C; Li J; Hou D; Luo Y; Zhang S; Jin Z; Shen L; Zhong P; Wu D
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105526. PubMed ID: 33338704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Dourado Sotero F; Calçada A; Aguiar de Sousa D; Dias M; Fonseca AC; Pinho E Melo T; Canhão P
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105718. PubMed ID: 33838517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Insulin Resistance Level is Associated with Worse Clinical Response in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Bas DF; Ozdemir AO; Colak E; Kebapci N
    Transl Stroke Res; 2016 Jun; 7(3):167-71. PubMed ID: 26830777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
    Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
    Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis.
    Wang J; Jiang Y; Zeng D; Zhou W; Hong X
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105055. PubMed ID: 32807461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.
    Chen C; Wang X; Chen X; Ouyang M; Sun L; Arima H; Robinson T; Lindley RI; Chalmers J; Li G; Song L; Anderson CS;
    Cerebrovasc Dis; 2021; 50(5):560-566. PubMed ID: 34153968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of post thrombolytic intracerebral hemorrhage volume on 90-day outcomes in acute ischemic stroke patients.
    Gillani SA; Ma X; Huang Y; Bains NK; Fakih R; Siddiq F; French BR; Gomez CR; Lyden PD; Qureshi AI
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107962. PubMed ID: 39191317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
    Suzuki K; Matsumaru Y; Takeuchi M; Morimoto M; Kanazawa R; Takayama Y; Kamiya Y; Shigeta K; Okubo S; Hayakawa M; Ishii N; Koguchi Y; Takigawa T; Inoue M; Naito H; Ota T; Hirano T; Kato N; Ueda T; Iguchi Y; Akaji K; Tsuruta W; Miki K; Fujimoto S; Higashida T; Iwasaki M; Aoki J; Nishiyama Y; Otsuka T; Kimura K;
    JAMA; 2021 Jan; 325(3):244-253. PubMed ID: 33464334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
    Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
    Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
    Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
    Hu D; Ding C; Jiang X; Xiao J; Li C; Zhang L; Li T; Ji Y; Peng Y; Luo X; Sheng L; Wang Q; Wu H
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105587. PubMed ID: 33450606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience.
    Cui Y; Zhou ZH; Hou XW; Chen HS
    Cerebrovasc Dis Extra; 2020; 10(3):148-158. PubMed ID: 33091902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
    Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
    Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.
    Guo Y; Yang Y; Zhou M; He L
    Stroke Vasc Neurol; 2018 Dec; 3(4):203-208. PubMed ID: 30637125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Non-Traditional Lipid Parameters with Hemorrhagic Transformation and Clinical Outcome After Thrombolysis in Ischemic Stroke Patients.
    Luo Y; Chen J; Yan XL; Jin H; Sun X; Guo ZN; Yang Y
    Curr Neurovasc Res; 2020; 17(5):736-744. PubMed ID: 33397260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study.
    You S; Wang Y; Wang X; Maeda T; Ouyang M; Han Q; Li Q; Song L; Zhao Y; Chen C; Delcourt C; Ren X; Carcel C; Zhou Z; Cao Y; Liu CF; Zheng D; Arima H; Robinson TG; Chen X; Lindley RI; Chalmers J; Anderson CS
    J Am Heart Assoc; 2024 Sep; 13(18):e036109. PubMed ID: 39258531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Unsuspected Infective Endocarditis.
    Gopal M; Lakhani S; Lee VH
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105502. PubMed ID: 33360518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.